Other Information
+Added: First Amendment to Loan and Security Agreement, dated as of April 8, 2022, between the Company and Melt Pharmaceuticals, Inc.
Certification of Mark L.
13 unchanged sentences
XBRL Taxonomy Extension Presentation Linkbase Document
−Removed: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2022, has been formatted in Inline
+Added: cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, has been formatted in Inline
of this exhibit have been omitted in compliance with Item 601 of Regulation S-K.
1 unchanged sentence
the undersigned, thereunto duly authorized.
+Added: August 9, 2022
Executive Officer and Director
Executive Officer)
−Removed: Chief Financial Officer
−Removed: (Principal Financial and Accounting Officer)
+Added: Financial Officer
+Added: Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.